Angelini: Angelini Pharma, Cureverse enter exclusive global option agreement to develop & commercialize innovative brain health asset, CV01
Angelini Pharma, part of the privately owned Angelini Industries, and Cureverse Inc., an early─stage research and development company, announced that they entered into an exclusive global option agreement for
Read full article »
Angelini Acraf manufactures and distributes food ingredients, medical products and dietary supplements.
Read more